BioSpace News Archive

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”) today announced it has entered into an option agreement for the sale of the assets of Purnovate, Inc. (“Purnovate”), a wholly owned subsidiary of Adial, to Adenomed, LLC (“Adenomed”), a new company formed by Purnovate CEO, William Stilley, founder and former CEO of Adial.

Healint, the developer and owner of Migraine Buddy – the world’s largest migraine tracking and research platform used by more than 3 million people and tens of thousands of migraine and pain clinics – and www.weather-migraine.com - The world first hyperlocal & AI based migraine weather-forecast website - is announcing a collaboration today with the University of Toronto.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that GSK has initiated two randomized, double-blind, placebo-controlled Phase 3 studies evaluating the safety and efficacy of bepirovirsen (formerly IONIS-HBVRx), an investigational antisense medicine for the treatment of patients with chronic hepatitis B infection (CHB).

OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare®, received an order valued at approximately $3 million to provide patient monitoring solutions and support services to a Canadian based hospital.

Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced a collaboration with AbVacc, Inc. (“AbVacc”) for the joint development of vaccine candidates targeting monkeypox and Marburg virus disease (“MVD”).

NERVTEX’s MoDAS (Movement Dysfunction Assessment Software) system, which is a First-in-Class Artificial Intelligence/Machine Learning (AI/ML)- based Software as a Medical Device(SaMD) for the analysis of motor symptoms of Parkinson’s disease and other movement disorders, has been approved by the China National Medical Products Administration, making it the first video-based AI-powered medical device for the assessment of movement disorders.

Zynex, Inc. (NASDAQ: ZYXI) today reported it will be hosting a blood donation drive on February 1, 2023 at its headquarters in Englewood, CO in partnership with Vitalant, the nation’s largest independent, nonprofit blood services provider.

Sharps Technology, Inc. today announced that it entered into a securities purchase agreement with institutional investors for aggregate gross proceeds of approximately $3.8 million priced at the market under Nasdaq rules.

Digital Diagnostics – maker of IDx-DR, the first-ever FDA-cleared, fully autonomous AI system for the diagnosis of diabetic retinopathy – announced today a strategic partnership with Tamer Healthcare – an integrated healthcare and wellness firm with more than 100 years of established business in the Kingdom of Saudi Arabia – to further enhance healthcare and innovation in the Kingdom of Saudi Arabia.

Leading the commercialization of the Solupore® Platform for Next-Generation Gene-Modified Cell Therapies with Superior Cell Health and Functionality